Extranodal Marginal Zone Lymphoma
📧 Sign up to get email alerts when something new happens for Extranodal Marginal Zone Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-03Clinical Trial Update: Mosunetuzumab in Patients With Newly Diagnosed Extranodal Marginal Zone Lymphoma [Phase 2]
Phase 2 clinical trial evaluating mosunetuzumab for newly diagnosed extranodal marginal zone lymphoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-01-30Clinical Trial Update: Clarithromycin + Lenalidomide Combination: a Full Oral Treatment for Patients With Relapsed/Refractory Extranodal Marginal Zone Lymphoma [Phase 2]
Phase 2 trial evaluating an all-oral combination of clarithromycin and lenalidomide for relapsed or refractory mucosa-associated lymphoid ti…
-
CLINICAL_TRIALS trial_result · 2023-03-21Clinical Trial Update: Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas [Phase 2]
Phase 2 trial of pembrolizumab alone or with idelalisib or ibrutinib in relapsed/refractory chronic lymphocytic leukemia or various low-grad…
-
CLINICAL_TRIALS trial_result · 2017-05-22Clinical Trial Update: Rituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell Lymphoma [Phase 2]
Phase 2 trial evaluating rituximab in patients undergoing donor peripheral blood stem cell transplantation for relapsed or refractory B-cell…